Search Results - "Maloum, K."

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion by Toma, A, Kosmider, O, Chevret, S, Delaunay, J, Stamatoullas, A, Rose, C, Beyne-Rauzy, O, Banos, A, Guerci-Bresler, A, Wickenhauser, S, Caillot, D, Laribi, K, De Renzis, B, Bordessoule, D, Gardin, C, Slama, B, Sanhes, L, Gruson, B, Cony-Makhoul, P, Chouffi, B, Salanoubat, C, Benramdane, R, Legros, L, Wattel, E, Tertian, G, Bouabdallah, K, Guilhot, F, Taksin, A L, Cheze, S, Maloum, K, Nimuboma, S, Soussain, C, Isnard, F, Gyan, E, Petit, R, Lejeune, J, Sardnal, V, Renneville, A, Preudhomme, C, Fontenay, M, Fenaux, P, Dreyfus, F

“…After failure of erythropoiesis-stimulating agents (ESAs), lenalidomide (LEN) yields red blood cell (RBC) transfusion independence (TI) in 20–30% of lower-risk…”
Get full text

Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion by Le Garff-Tavernier, M, Herbi, L, de Romeuf, C, Nguyen-Khac, F, Davi, F, Grelier, A, Boudjoghra, M, Maloum, K, Choquet, S, Urbain, R, Vieillard, V, Merle-Béral, H

Get full text

Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1 by Cosson, A, Chapiro, E, Bougacha, N, Lambert, J, Herbi, L, Cung, H-A, Algrin, C, Keren, B, Damm, F, Gabillaud, C, Brunelle-Navas, M-N, Davi, F, Merle-Béral, H, Le Garff-Tavernier, M, Roos-Weil, D, Choquet, S, Uzunov, M, Morel, V, Leblond, V, Maloum, K, Lepretre, S, Feugier, P, Lesty, C, Lejeune, J, Sutton, L, Landesman, Y, Susin, S A, Nguyen-Khac, F

Get full text

Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia by KANNENGIESSER, Caroline, SANCHEZ, Mayka, LASCAUX, Axelle, PONDARRE, Corinne, SEVILLA NAVARRO, Julian, VIDYATILAKE, Sudharma, BEAUMONT, Carole, GRANDCHAMP, Bernard, MAY, Alison, SWEENEY, Marion, HETET, Gilles, KERR, Briedgeen, MORAN, Erica, FUSTER SOLER, Jose L, MALOUM, Karim, MATTHES, Thomas, OUDOT, Caroline

“…Congenital sideroblastic anemias are rare disorders with several genetic causes; they are characterized by erythroblast mitochondrial iron overload, differ…”
Get full text

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics by ROCHE-LESTIENNE, C, LEPERS, S, DIB, M, PHILIPPE, N, CAMBIER, N, BARETE, S, LIBERSA, C, BLETRY, O, HATRON, P.-Y, QUESNEL, B, ROSE, C, MALOUM, K, SOENEN-CORNU, V, BLANCHET, O, FENAUX, P, PRIN, L, PREUDHOMME, C, KAHN, J.-E, LAI, J.-L, HACHULLA, E, DRUPT, F, DEMARTY, A.-L, ROUMIER, A.-S, GARDEMBAS, M

“…Idiopathic hypereosinophilic syndrome (HES) characterized by unexplained and persistent hypereosinophilia is heterogeneous and comprises several entities: a…”
Get full text

Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes by VASCONCELOS, Y, DE VOS, J, MALOUM, K, AJCHENBAUM-CYMBALISTA, F, TROUSSARD, X, LEPORRIER, M, KLEIN, B, DIGHIERO, G, DAVI, F, VALLAT, L, REME, T, LALANNE, Al, WANHERDRICK, K, MICHEL, A, NGUYEN-KHAC, F, OPPEZZO, P, MAGNAC, C

Get full text

5.37 Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Fludarabine plus Cyclophosphamide plus Rituximab in Patients with CLL by Maloum, K, Settegrana, C, Dupuis, J, Brion, A, Zini, J, Dreyfus, B, Cymbalista, F, Nguyen-Khac, F, Leblond, V

Get full text

Absence of microsatellite instability in human chronic lymphocytic leukaemia B cells by Praz, F, Le Page, F, Vallat, L, Davi, F, Nguyen-Khac, F, Maloum, K, Delic, J, Merle-Béral, H

Get full text

2.41 Clinical Significance of Sex Chromosome Loss in Chronic Lymphocytic Leukemia by Antony-Debré, I, Marchay, N, Parizot, C, Chapiro, E, Cung, H.A, Mathis, S, Grelier, A, Maloum, K, Choquet, S, Davi, F, Azgui, Z, Uzunov, M, Leblond, V, Merle-Béral, H, Sutton, L, Nguyen-Khac, F

Get full text

Basic biology of autoimmune phenomena in chronic lymphocytic leukemia by Pritsch, O, Maloum, K, Dighiero, G

“…There is evidence indicating that autoreactive B cells constitute a substantial part of the B cell repertoire. This autoreactive repertoire secretes the…”
Get more information

Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia by SUTTON, L, MALOUM, K, MERLE-BERAL, H, BINET, J.-L, GONZALEZ, H, ZOUABI, H, AZAR, N, BOCCACCIO, C, CHARLOTTE, F, COSSET, J.-M, GABARRE, J, LEBLOND, V

“…Given the generally poor outcome of advanced B cell chronic lymphocytic leukemia, experimental approaches are warranted, especially for younger patients in…”
Get full text

VH gene expression in hairy cell leukaemia by MALOUM, K, MAGNAC, C, AZGUI, Z, CAU, C, CHARLOTTE, F, BINET, J. L, MERLE-BERAL, H, DIGHIERO, G

“…Hairy cells are characterized by their typical morphology and expression of specific surface antigens. Although their B‐cell origin is now confirmed, their…”
Get full text

Analysis of VH Gene Expression in CD5+ and CD5− B-Cell Chronic Lymphocytic Leukemia by Maloum, K., Davi, F., Magnac, C., Pritsch, O., McIntyre, E., Valensi, F., Binet, J.L., Merle-Béral, H., Dighiero, G.

“…In contrast to highly mutated follicular lymphomas and multiple myelomas, chronic lymphocytic leukemias (CLLs) frequently express VH genes in germline…”
Get full text

VH Gene Expression in CD5 Positive and CD5 Negative B Cell Chronic Lymphoid Malignancies by Maloum, K., Pritsch, O., Magnac, C., Davi, F., Binet, J. L., Merle-Beral, H., Dighiero, G.

“…In this review, we report analyses of VH genes in mature B cell malignancies generally or occasionally bearing CD5 antigen such as B CLL, MCL, SLVL and PLL. In…”
Get full text

Un syndrome VEXAS chez une femme sans monosomie X by Camard, M., Hirsh, P., Chapiro, E., Maloum, K., Bravetti, C., Abermil, N., Kosmider, O., Morel, V., Theves, F.

Get full text

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients by Leporrier, Michel, Chevret, Sylvie, Cazin, Bruno, Boudjerra, Najda, Feugier, Pierre, Desablens, Bernard, Rapp, Marie-José, Jaubert, Jerome, Autrand, Claudie, Divine, Marine, Dreyfus, Brigitte, Maloum, Karim, Travade, Philippe, Dighiero, Guillaume, Binet, Jacques-Louis, Chastang, Claude

“…To comparatively assess first-line treatment with fludarabine and 2 anthracycline-containing regimens, namely CAP (cyclophosphamide, doxorubicin plus…”
Get full text

Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement by Maloum, K, Pritsch, O, Dighiero, G

“…In B-cell malignancies, the uniqueness of the immunoglobulin heavy chain locus (IgH) clonal rearrangement provides a useful marker for the detection of minimal…”
Get more information

Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL) by Magnac, C, Sutton, L, Cazin, B, Laurent, C, Binet, J L, Merle-Béral, H, Dighiero, G, Maloum, K

“…In the absence of specific chromosomal translocations the best method for detecting minimal residual disease (MRD) in B cell malignancies is based on the…”
Get more information

Un syndrome d'Evans révélant une maladie de Castleman by Roux, D, Teixeira, A, Rémy, J, Maloum, K, Herson, S, Cherin, P

Get full text

Petit mais costaud by Roux, D., Teixeira, A., Rémy, J., Maloum, K., Charlotte, F., Herson, S., Chérin, P.

Get full text